Proportion of infants without regurgitation or vomiting at the end of intervention period (asymptomatic infants) · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
Feed thickener may leads to higher proportion of infants without regurgitation or vomiting at the end… compared with control (low certainty).
1 finding from 1 review
Reflux index (percentage of time pH < 4) · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
Number of reflux episodes lasting > 5 minutes · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
Duration of longest reflux episode · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
Diarrhoea · Formula‐fed healthy term infants up to 6 months of age with gastro‐oesophageal reflux
1 finding from 1 review
Dry mouth (xerostomia) · Adults seeking treatment for the symptom of dry mouth (xerostomia) due to any cause (e.g. medication, Sjogren's syndrome, radiotherapy,…
1 finding from 1 review
Intervention not reported
Treatment failure day‐28 PCR‐adjusted(PP population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failure day‐28 PCR‐adjusted(PP population) (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failureday‐28 PCR‐adjusted(ITT population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failureday‐28 PCR‐adjusted(ITT population) (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Drug‐related adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention probably leads to lower drug‐related adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Drug‐related vomiting · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in drug‐related vomiting (low certainty).
1 finding from 1 review
Intervention not reported
Acceptability · children aged 14 years or younger with uncomplicated P falciparum malaria
1 finding from 1 review
Intervention not reported
Weight gain (g/kg/d) · preterm infants
1 finding from 1 review
Intervention not reported
Length gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Head circumference gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Mental Development Index (MDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Psychomotor Development Index (PDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · preterm infants
The intervention showed no clear difference in necrotising enterocolitis (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failure · treating pulmonary TB
The intervention showed no clear difference in treatment failure (moderate certainty).
1 finding from 1 review
Intervention not reported
Relapse · treating pulmonary TB
The intervention showed no clear difference in relapse (low certainty).
1 finding from 1 review